Isaac J. Powell
The University of Texas at San Antonio Health Science Center
Papers
1
Total Citations
62
H-Index
1
About
Isaac J. Powell is a pioneering urologic oncologist whose research has fundamentally shaped the understanding and treatment of prostate cancer, with a particular focus on health disparities and aggressive disease. His landmark work includes leading the Southwest Oncology Group’s Phase II Study 9109, which demonstrated the feasibility and long-term efficacy of neoadjuvant therapy prior to radical prostatectomy for patients with clinical T3/T4 prostate cancer. This highly cited study (62 citations) provided critical evidence that preoperative systemic therapy could improve outcomes for locally advanced disease, influencing clinical guidelines for decades. Beyond this, Powell has been a leading voice in investigating the biological and social determinants of prostate cancer outcomes among African American men, consistently showing that race-associated disparities are driven by both genetic susceptibility and unequal access to care. His contributions have earned him numerous honors, including the American Urological Association’s Distinguished Service Award. With a career spanning over 30 years, Powell’s work continues to guide both surgical practice and health equity research, making him an essential figure for any student or researcher studying prostate cancer.
Research Focus
Key Achievements
Top Papers
- 1